Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Clinical and neurophysiologic evaluation of the effect of Cisplatin administration on the motor nerves.

Marzorati L, Bogliun G, Cavaletti G.

Int J Oncol. 1993 Jan;2(1):81-4.

PMID:
21573518
2.

Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function.

Krarup-Hansen A, Fugleholm K, Helweg-Larsen S, Hauge EN, Schmalbruch H, Trojaborg W, Krarup C.

Brain. 1993 Oct;116 ( Pt 5):1017-41.

PMID:
8221046
3.

Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy.

Gao WQ, Dybdal N, Shinsky N, Murnane A, Schmelzer C, Siegel M, Keller G, Hefti F, Phillips HS, Winslow JW.

Ann Neurol. 1995 Jul;38(1):30-7.

PMID:
7611721
4.

Inhibition of Mitochondrial p53 Accumulation by PFT-μ Prevents Cisplatin-Induced Peripheral Neuropathy.

Maj MA, Ma J, Krukowski KN, Kavelaars A, Heijnen CJ.

Front Mol Neurosci. 2017 Apr 18;10:108. doi: 10.3389/fnmol.2017.00108. eCollection 2017.

5.

Agmatine co-treatment attenuates allodynia and structural abnormalities in cisplatin-induced neuropathy in rats.

Donertas B, Cengelli Unel C, Aydin S, Ulupinar E, Ozatik O, Kaygisiz B, Yildirim E, Erol K.

Fundam Clin Pharmacol. 2018 Jun;32(3):288-296. doi: 10.1111/fcp.12351. Epub 2018 Mar 13. Erratum in: Fundam Clin Pharmacol. 2018 Dec;32(6):678.

PMID:
29377255
6.

Curcumin Ameliorates Functional and Structural Abnormalities in Cisplatin-induced Neuropathy.

Agthong S, Kaewsema A, Charoensub T.

Exp Neurobiol. 2015 Jun;24(2):139-45. doi: 10.5607/en.2015.24.2.139. Epub 2015 Apr 27.

7.

Effects of repeated administration of low doses of cisplatin on the rat nervous system.

Cavaletti G, Petruccioli MG, Tredici G, Marmiroli P, Barajon I, Fabbrica D, Di Francesco A.

Int J Tissue React. 1991;13(3):151-7.

PMID:
1960015
8.

Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.

Meijer C, de Vries EG, Marmiroli P, Tredici G, Frattola L, Cavaletti G.

Neurotoxicology. 1999 Dec;20(6):883-7.

PMID:
10693969
9.

Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.

Carozzi VA, Canta A, Oggioni N, Sala B, Chiorazzi A, Meregalli C, Bossi M, Marmiroli P, Cavaletti G.

Exp Neurol. 2010 Dec;226(2):301-9. doi: 10.1016/j.expneurol.2010.09.004. Epub 2010 Sep 9.

PMID:
20832406
10.

Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy.

Barajon I, Bersani M, Quartu M, Del Fiacco M, Cavaletti G, Holst JJ, Tredici G.

Exp Neurol. 1996 Mar;138(1):93-104.

PMID:
8593900
11.

[Neuropathy caused by cisplatin. Clinical, electrophysiological and morphological study].

Gastaut JL, Pellissier JF.

Rev Neurol (Paris). 1985;141(10):614-26. French.

PMID:
3003868
12.
13.

Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies.

Krarup-Hansen A, Helweg-Larsen S, Schmalbruch H, Rørth M, Krarup C.

Brain. 2007 Apr;130(Pt 4):1076-88. Epub 2007 Feb 14.

PMID:
17301082
14.

Upregulations of P2X(3) and ASIC3 involve in hyperalgesia induced by cisplatin administration in rats.

Hori K, Ozaki N, Suzuki S, Sugiura Y.

Pain. 2010 May;149(2):393-405. doi: 10.1016/j.pain.2010.03.005. Epub 2010 Apr 8.

PMID:
20378247
15.

Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findings.

Briani C, Campagnolo M, Lucchetta M, Cacciavillani M, Dalla Torre C, Granata G, Bergamo F, Lonardi S, Zagonel V, Cavaletti G, Ermani M, Padua L.

Eur J Neurol. 2013 Jan;20(1):188-92. doi: 10.1111/j.1468-1331.2012.03852.x. Epub 2012 Sep 4.

PMID:
22943629
16.

Off-treatment course of cisplatin-induced dorsal root ganglia neuronopathy in rats.

Cavaletti G, Tredici G, Marmiroli P, Fabbrica D, Braga M.

In Vivo. 1994 May-Jun;8(3):313-6.

PMID:
7803710
17.

The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.

Van Brakel WH, Nicholls PG, Das L, Barkataki P, Maddali P, Lockwood DN, Wilder-Smith E.

Lepr Rev. 2005 Dec;76(4):277-95.

PMID:
16411508
18.

Morphological and electrophysiological study of the effects of cisplatin and ORG.2766 on rat spinal ganglion neurons.

Müller LJ, Gerritsen van der Hoop R, Moorer-van Delft CM, Gispen WH, Roubos EW.

Cancer Res. 1990 Apr 15;50(8):2437-42.

19.

Depletion of Mitofusin-2 Causes Mitochondrial Damage in Cisplatin-Induced Neuropathy.

Bobylev I, Joshi AR, Barham M, Neiss WF, Lehmann HC.

Mol Neurobiol. 2018 Feb;55(2):1227-1235. doi: 10.1007/s12035-016-0364-7. Epub 2017 Jan 21.

PMID:
28110471
20.

Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.

Khasabova IA, Khasabov S, Paz J, Harding-Rose C, Simone DA, Seybold VS.

J Neurosci. 2012 May 16;32(20):7091-101. doi: 10.1523/JNEUROSCI.0403-12.2012.

Supplemental Content

Support Center